Literature DB >> 19350261

Fatal and severe codeine intoxication in 3-year-old twins--interpretation of drug and metabolite concentrations.

Nerea Ferreirós1, Sebastian Dresen, Maren Hermanns-Clausen, Volker Auwaerter, Annette Thierauf, Christoph Müller, Roland Hentschel, Rainer Trittler, Gisela Skopp, Wolfgang Weinmann.   

Abstract

This work presents two cases of codeine intoxication in 3-year-old monozygotic twin brothers while treated with a codeine slow-release formulation. One child had to be admitted to the hospital, whereas the other one died at home after aspiration of gastric content. The concentrations of codeine and major metabolites including morphine and corresponding glucuronide conjugates were measured by liquid chromatography-tandem mass spectrometry in serum, urine, cerebrospinal fluid, and brain tissue, respectively. A genetic polymorphism study was carried out in order to determine the ability of the children to metabolize codeine by O-demethylation. A pharmacokinetic calculation was also performed to estimate the administered dose of codeine in question. High concentrations of all substances were found in samples of both children. The pharmacokinetic estimate suggests an overdose of codeine, and the possible reasons for the high opiate concentrations are discussed. Furthermore, the postmortem distribution--during and after resuscitation--might play a major role in the interpretation of postmortem concentration levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350261     DOI: 10.1007/s00414-009-0340-0

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  24 in total

Review 1.  Preanalytic aspects in postmortem toxicology.

Authors:  G Skopp
Journal:  Forensic Sci Int       Date:  2004-06-10       Impact factor: 2.395

2.  Human UGT2B7 catalyzes morphine glucuronidation.

Authors:  B L Coffman; G R Rios; C D King; T R Tephly
Journal:  Drug Metab Dispos       Date:  1997-01       Impact factor: 3.922

3.  Polymorphic O-demethylation of codeine.

Authors:  Z R Chen; A A Somogyi; F Bochner
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

Review 4.  Pharmacokinetic-pharmacodynamic modeling of opioids.

Authors:  Jörn Lötsch
Journal:  J Pain Symptom Manage       Date:  2005-05       Impact factor: 3.612

5.  Liquid medication dosing errors.

Authors:  D J Madlon-Kay; F S Mosch
Journal:  J Fam Pract       Date:  2000-08       Impact factor: 0.493

Review 6.  Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I.

Authors:  Scott C Armstrong; Kelly L Cozza
Journal:  Psychosomatics       Date:  2003 Mar-Apr       Impact factor: 2.386

7.  2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS).

Authors:  Alvin C Bronstein; Daniel A Spyker; Louis R Cantilena; Jody Green; Barry H Rumack; Stuart E Heard
Journal:  Clin Toxicol (Phila)       Date:  2007-12       Impact factor: 4.467

8.  Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation.

Authors:  A Wahlström; L Lenhammar; B Ask; A Rane
Journal:  Pharmacol Toxicol       Date:  1994-07

9.  [Biopharmaceutic properties of slow-release codeine phosphate. Drug release from ion exchangers in vitro and in vivo].

Authors:  A Wildfeuer; G Pfaff; P Lach
Journal:  Arzneimittelforschung       Date:  1994-06

10.  Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.

Authors:  M D Green; C D King; B Mojarrabi; P I Mackenzie; T R Tephly
Journal:  Drug Metab Dispos       Date:  1998-06       Impact factor: 3.922

View more
  7 in total

1.  Pharmacogenetics raises new legal questions.

Authors:  Stu Hutson
Journal:  Nat Med       Date:  2010-07       Impact factor: 53.440

Review 2.  Genetic variability of pain perception and treatment--clinical pharmacological implications.

Authors:  Jörn Lötsch
Journal:  Eur J Clin Pharmacol       Date:  2011-02-23       Impact factor: 2.953

3.  Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.

Authors:  Ana de Castro; Hendreé E Jones; Rolley E Johnson; Teresa R Gray; Diaa M Shakleya; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-08       Impact factor: 3.681

4.  Pharmacogenomics of codeine, morphine, and morphine-6-glucuronide: model-based analysis of the influence of CYP2D6 activity, UGT2B7 activity, renal impairment, and CYP3A4 inhibition.

Authors:  Thomas Eissing; Jörg Lippert; Stefan Willmann
Journal:  Mol Diagn Ther       Date:  2012-02-01       Impact factor: 4.074

5.  Outpatient Opioid Prescriptions for Children and Opioid-Related Adverse Events.

Authors:  Cecilia P Chung; S Todd Callahan; William O Cooper; William D Dupont; Katherine T Murray; Andrew D Franklin; Kathi Hall; Judith A Dudley; C Michael Stein; Wayne A Ray
Journal:  Pediatrics       Date:  2018-07-16       Impact factor: 7.124

6.  Development of an algorithm to identify serious opioid toxicity in children.

Authors:  Cecilia P Chung; S Todd Callahan; William O Cooper; Katherine T Murray; Kathi Hall; Judith A Dudley; C Michael Stein; Wayne A Ray
Journal:  BMC Res Notes       Date:  2015-07-04

7.  Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children.

Authors:  Ida Aka; Christiana J Bernal; Robert Carroll; Angela Maxwell-Horn; Kazeem A Oshikoya; Sara L Van Driest
Journal:  J Pers Med       Date:  2017-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.